Laregab 100 Capsule contains Gabapentin 100 mg, an anticonvulsant medication primarily indicated for the management of partial seizures and neuropathic pain. Gabapentin exerts its therapeutic effects by modulating the activity of voltage-gated calcium channels in the central nervous system, thereby reducing neuronal excitability and abnormal firing. It is commonly prescribed as adjunctive therapy in epilepsy and for the relief of neuropathic pain conditions such as postherpetic neuralgia and diabetic neuropathy. Laregab 100 Capsule is well-absorbed orally, with peak plasma concentrations typically achieved within 2 to 3 hours post-administration. The drug is not significantly metabolized in the liver and is excreted unchanged via the kidneys, necessitating dosage adjustments in patients with renal impairment. Common adverse effects include dizziness, somnolence, peripheral edema, and fatigue, which are generally dose-dependent and tend to diminish over time. Laregab should be used cautiously in patients with a history of hypersensitivity to gabapentin or related compounds. Abrupt discontinuation should be avoided to minimize the risk of withdrawal seizures. This medication should be used under strict medical supervision with appropriate monitoring to ensure optimal therapeutic outcomes and minimize potential adverse effects.